Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V.filedCriticalAkzo Nobel N.V.
Priority to HU9903097ApriorityCriticalpatent/HUP9903097A3/en
Publication of HUP9903097A2publicationCriticalpatent/HUP9903097A2/en
Publication of HUP9903097A3publicationCriticalpatent/HUP9903097A3/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Contraceptive and/or hormone replacement therapy (HRT) kit comprises sequential daily dosage units comprising either: (a) a progestogen as contraceptive; or (b) a progestogen and/or an oestrogen as HRT, and two dosage units comprising an anti-progestogen. Also claimed is the use of daily dosage units in drug delivery systems comprising progestogen and/or oestrogen, and 2-7 dosage units anti-progestogen, one administered at the beginning and the remainder regularly divided throughout the cycle.
Hormone replacement therapy kit and / or contraceptive use of daily dosage units consisting essentially of a progestogen and process of preparing a drug delivery system
HORMONE REPLACEMENT THERAPY METHOD AND HORMONE DISPENSER Varying the daily dose of either or both of the estrogen and the progestogen administered for hormone replacement therapy (HRT) is readily and inexpensively accomplished, without the necessity